Monday, December 8, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Earnings

Immersion Faces Nasdaq Compliance Challenge Over Delayed Filing

Andreas Sommer by Andreas Sommer
September 4, 2025
in Earnings, Nasdaq, Tech & Software
0
Immersion Stock
0
SHARES
200
VIEWS
Share on FacebookShare on Twitter

Shares of Immersion Corporation came under scrutiny after the haptics technology specialist received a formal notification from the Nasdaq stock market regarding a compliance issue. The alert, issued on August 20, 2025, stems from the company’s failure to timely file its Annual Report on Form 10-K for the fiscal year that concluded on April 30, 2025.

The delay is directly connected to an ongoing internal investigation being conducted by the audit committee of Barnes & Noble Education (BNED), a subsidiary of Immersion. This development has introduced significant uncertainty for investors, prompting heightened attention to the company’s regulatory compliance efforts.

Key Details of the Notification:
* Notification Date: August 20, 2025
* Nature of Breach: Late submission of the Form 10-K annual report
* Root Cause: Internal probe at subsidiary Barnes & Noble Education (BNED)
* Response Deadline: 60 calendar days to submit a plan to regain compliance

Should investors sell immediately? Or is it worth buying Immersion?

In response to the notification, Immersion now has a 60-day window to present a detailed plan to Nasdaq outlining its path to rectifying this filing delinquency. A failure to satisfy the exchange’s requirements could lead to further disciplinary actions, including the potential for the stock’s delisting.

Reflecting the cautious market sentiment, Immersion’s stock closed its latest session at $7.01. The immediate focus for the company is squarely on resolving the filing delay and navigating the complexities of the internal investigation at BNED.

Despite these recent regulatory headwinds, some market analysts maintain a measured outlook on the stock’s potential. The current average price target among covering analysts stands at $12.25. This figure suggests a substantial upside potential of over 75% from the recent closing price of $6.99. While the average broker recommendation has softened from 1.50 to 2.00, it continues to signal an overall positive assessment of the company’s long-term value.

Ad

Immersion Stock: Buy or Sell?! New Immersion Analysis from December 8 delivers the answer:

The latest Immersion figures speak for themselves: Urgent action needed for Immersion investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 8.

Immersion: Buy or sell? Read more here...

Tags: Immersion
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Pony AI Stock
AI & Quantum Computing

Pony AI Gains Momentum with Strategic Moves and Institutional Backing

December 8, 2025
Ginkgo Bioworks Holdings Registered (A) Stock
Analysis

Ginkgo Bioworks Shares Surge on Major Government Contract Win

December 8, 2025
AbbVie Stock
Analysis

Navigating Oncology Rivals: AbbVie’s Strategic Position Under Scrutiny

December 8, 2025
Next Post
G1 Therapeutics Stock

G1 Therapeutics Acquisition Finalized in Landmark $405M Deal

Monopar Therapeutics Stock

Monopar Therapeutics Stock Surges on Clinical Progress and Analyst Optimism

Voyager Therapeutics Stock

Voyager Therapeutics Stock Gains Momentum Following Investor Conference Appearances

Recommended

Blink Charging Stock

Blink Charging’s Critical Earnings Test Approaches

1 month ago
Centrus Energy Stock

A Quiet Leader Emerges in the Nuclear Energy Revival

3 months ago
Costco Stock

Costco’s Bold Membership Strategy: Rewarding Premium Customers

3 months ago
UiPath Registered (A) Stock

UiPath Leadership Under Scrutiny Ahead of Earnings Report

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Prospect Capital Faces Analyst Doubts Amid Strategic Shift

Lennar Shares Face Cautious Outlook Amid Housing Market Uncertainty

Bath & Body Works Stock: Assessing the Post-Candle Day Landscape

IBM’s Strategic Gambit: A Potential $11 Billion Acquisition of Confluent

Analyst Confidence Rises for Royal Gold’s Stock Trajectory

Arrowhead Pharmaceuticals Enters Commercial Era with Landmark Drug Approval

Trending

Pony AI Stock
AI & Quantum Computing

Pony AI Gains Momentum with Strategic Moves and Institutional Backing

by Felix Baarz
December 8, 2025
0

The autonomous driving technology firm Pony AI is entering the week bolstered by a series of strategic...

Ginkgo Bioworks Holdings Registered (A) Stock

Ginkgo Bioworks Shares Surge on Major Government Contract Win

December 8, 2025
AbbVie Stock

Navigating Oncology Rivals: AbbVie’s Strategic Position Under Scrutiny

December 8, 2025
Prospect Capital Stock

Prospect Capital Faces Analyst Doubts Amid Strategic Shift

December 8, 2025
Lennar Stock

Lennar Shares Face Cautious Outlook Amid Housing Market Uncertainty

December 8, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Pony AI Gains Momentum with Strategic Moves and Institutional Backing
  • Ginkgo Bioworks Shares Surge on Major Government Contract Win
  • Navigating Oncology Rivals: AbbVie’s Strategic Position Under Scrutiny

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com